Global Recombinant Vaccines Market
Recombinant Vaccines Research Report 2024: Market Poised for Accelerated Growth, Set to Reach $34.18 Billion by 2034 from $10.14 Billion in 2023
January 31, 2024 11:23 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034" report has been added to's offering. The global...
Global Malaria Vaccine Market
Global Malaria Vaccine Market Set for Remarkable Growth in the Fight Against Malaria
October 31, 2023 08:08 ET | Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Malaria Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to's...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Malaria Vaccine Patent Granted in Brazil, the 25th Patent Allowance for Programs in Infectious Disease, Cancer and Fibrosis
June 08, 2023 08:01 ET | Ocean Biomedical, Inc.
Patent for breakthrough approach to disrupting the malaria parasite’s life cycle adds to a growing global patent portfolio, with 25 patents issued and an additional 38 patents pending. ...
GOVX new logo.png
GeoVax and Leidos Expand Collaboration to Malaria Vaccines
March 04, 2019 09:00 ET | GeoVax, Inc.
Supported by Contract from U.S. Agency for International Development (USAID) ATLANTA, GA, March 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...